Business
British Columbia reimburses REVESTIVE® (teduglutide for injection) for the treatment of Short Bowel Syndrome
Takeda Canada Inc. ("Takeda") announced that REVESTIVE® (teduglutide for injection) will now be reimbursed by BC PharmaCare for eligible pediatric and adult patients with Short Bowel Syndrome (SBS) who are dependent on parenteral support.1 Coverage is subject to specific criteria.2
About this update from Takeda Pharmaceutical Co. Ltd.
[{"type":"text","content":"TORONTO, May 5, 2026 /CNW/ - Takeda Canada Inc. ("Takeda") announced that REVESTIVE® (teduglutide for injection) will now be reimbursed by BC PharmaCare for eligible pediatric and adult patients with Short Bowel Syndrome (SBS) who are dependent on parenteral support.1 Coverage is subject to specific criteria.2","length":326,"tagName":"p"},{"type":"image","alt":"Takeda Canada (CNW Group/Takeda Canada Inc.)","displaySize":"","headline":null,"caption":"Takeda Canada (CNW Group/Takeda Canada Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":210,"url":"https://media.zenfs.com/en/cnwgroup.com/a66b3b000864561ec11d9d59b67c90d2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/7TdADUOcxEVoXbeCqmLsgg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM3MA--/https://media.zenfs.com/en/cnwgroup.com/a66b3b000864561ec11d9d59b67c90d2","width":400,"height":210}},"href":"https://mma.prnewswire.com/media/2972583/Takeda_Canada_Inc__British_Columbia_reimburses_REVESTIVE___tedug.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"For people living with SBS, reimbursed access can help reduce reliance on parenteral support, which includes intravenous administration of nutrition, fluids, and electrolytes.","length":175,"tagName":"p"},{"type":"text","content":""We welcome the Government of B.C.'s decision to reimburse REVESTIVE for people living with Short Bowel Syndrome. This decision is an important step toward improving equitable access to care and supporting better health outcomes," said Gail Attara, CEO and Co-founder of the Gastrointestinal Society and President of the Canadian Society of Intestinal Research. "Patient organizations have long engaged with provincial governments on the need for timely access to therapies for rare digestive disorders. We look forward to continuing to work collaboratively with policymakers and partners to strengthen access to appropriate treatments for Canadians living with complex GI conditions."","length":709,"tagName":"p"},{"type":"text","content":"SBS occurs when the small intestine is unable to absorb enough nutrients and fluids – often due to surgical removal, damage, or disease.3 People living with SBS may experience dehydration, malnutrition, fatigue, and weight loss, among other serious health impacts.3 Management can ...